Brooks Laboratories Ltd. Responds to Share Price Movement
Brooks Laboratories Ltd. addressed concerns regarding recent activity in its share price, according to a statement released on April 2, 2026. The company responded to a communication from BSE Limited, referencing a "Movement in Price Letter" dated April 1, 2026.Brooks Laboratories Ltd. affirmed that it has disclosed all material information relevant to the company’s operations and performance, adhering to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that no unpublished price-sensitive information is currently held that could influence share price or volume behavior.
Management stated that they are unaware of the cause for the observed changes in share price and volume, attributing the fluctuations to market-driven factors. The company emphasized its commitment to compliance with the Listing Regulations and applicable laws.
Krutika Rane, Company Secretary and Compliance Officer (Membership No.: 66310), signed the statement on behalf of Brooks Laboratories Ltd.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.